Nabriva Therapeutics: Q3 Earnings Insights

Nabriva Therapeutics NBRV reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Nabriva Therapeutics their estimated earnings by 12.5%, reporting an EPS of $-0.21 versus an estimate of $-0.24, which surprised analysts.

Revenue was up $7,571,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06, which was followed by a 0.86% increase in the share price the next day.

Here's a look at Nabriva Therapeutics's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.35 -0.67 -0.95 -1
EPS Actual -0.29 -0.53 -1.11 -0.9
Revenue Estimate 5.99M 2.25M 600.00K 450.00K
Revenue Actual 8.24M 2.53M 2.46M 1.29M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!